- Patient care has remained central to Dr. Masood’s decisions, even when protecting access to treatment required significant financial risk.
- KabaFusion’s national growth followed a deliberate “smiley face” strategy focused on major population centers.
- Bad debt and DSO are critical RCM metrics, but many revenue cycle problems begin upstream with intake, authorization and documentation.
- Dr. Masood believes IVIG will remain an important therapy despite payer pressure and the emergence of newer treatment options.
- Technology and data will play a growing role in improving operations, reporting and decision making across home infusion.
Welcome to Beyond the Drip, where we dive into the fascinating world of Infusion Pharmacy, from Home Infusion to Ambulatory Infusion Centers. Expect topical conversations on the latest happenings in Infusion from industry leaders who will bring you the latest news, trends and innovations in the infusion industry, as well as expert insights and stories to keep you informed and inspired.
In Episode 19, the hosts sit down with Dr. Sohail Masood, Founder, CEO and Chairman of KabaFusion, to discuss the experiences and principles that shaped his career in home infusion. From getting through pharmacy school on a Snickers bar a day to helping create pathways that allowed patients with rare neuromuscular diseases to receive IVIG at home, Dr. Sohail Masood’s career has been defined by persistence, patient advocacy and a willingness to take risks for the people he serves.
From arriving in the United States at 19 with little money to building national infusion companies, Dr. Masood shares how persistence, patient advocacy and a strong moral framework influenced his approach to leadership and growth. He reflects on the risks behind some of his biggest decisions, including continuing to provide IVIG to patients despite reimbursement uncertainty, as well as the lessons he has carried into KabaFusion’s expansion.
The conversation also explores revenue cycle management, payer relationships, IVIG and the growing role of technology and data in home infusion, offering a broader look at both the business and clinical challenges shaping the industry today.
Key Takeaways
- Patient care has remained central to Dr. Masood’s decisions, even when protecting access to treatment required significant financial risk.
- KabaFusion’s national growth followed a deliberate “smiley face” strategy focused on major population centers.
- Bad debt and DSO are critical RCM metrics, but many revenue cycle problems begin upstream with intake, authorization and documentation.
- Dr. Masood believes IVIG will remain an important therapy despite payer pressure and the emergence of newer treatment options.
- Technology and data will play a growing role in improving operations, reporting and decision making across home infusion.
The episode shows how Dr. Masood’s patient-first philosophy has remained consistent even as his companies have grown and the industry has become more complex.
For home infusion leaders, his story offers a clear message: build strong financial and operational systems, invest in people and technology and pursue growth without losing sight of the patients the organization exists to serve. It is a perspective shaped by decades of experience and by a belief that financial success should be the result of doing good work, not the reason for doing it.
Want to hear the stories and lessons behind Dr. Masood’s remarkable journey?
Listen to the full episode of Beyond the Drip for his perspective on building KabaFusion, putting patients first and navigating the future of home infusion.
Guest Speaker
Dr. Sohail Masood, Founder, CEO and Chairman of KabaFusion
Dr. Sohail Masood runs his businesses on a belief he's held since pharmacy school: grounding care firmly in empathy for both patients and healthcare professionals by restoring the humanity essential to quality care and better outcomes.
Prior to him starting Crescent Healthcare, patients with rare neuromuscular diseases had nowhere to turn but the hospital. He created the market and the reimbursement pathways that let them heal at home with IVIG.
Patient care has consistently been central to his mission. In 1997, when Medicare withdrew coverage for IVIG treatment for CIDP patients, he personally committed $2 million to ensure uninterrupted access to therapy, while simultaneously advocating before Medicare to reverse the decision, an effort that ultimately succeeded. His advocacy also helped secure Medicare coverage of IVIG for Pemphigus and Pemphigoid in 2003, expanding access beyond CIDP. When an IVIG shortage stalled a landmark Stiff Person Syndrome study, he donated the drug himself to keep the research moving forward.
Dr. Masood and pharmacist Mona Masood founded Ultracare in 1992, the seed that grew into Crescent Healthcare in 1995. He founded MAAS Medical to develop a state-of-the-art home infusion pump which was acquired by Baxter in 2007. He founded KabaFusion in 2010, now the largest independently owned privately held home infusion company in the U.S. with 33 pharmacies nationwide providing care to patients in 48 states.
Achievements and Honors:
3x Ernst & Young Entrepreneur of the Year. 1999 for Crescent Healthcare- 2017 and 2023 for KabaFusion.
2022 Gene Graves Lifetime Achievement Award. The National Home Infusion Association's highest honor, recognizing his 35+ years advocating for patients and the industry.
2019 USC Mann Most Distinguished Alumni Award. Honored by his alma mater for his philanthropy and service.
Beyond the Drip Co-hosts
Paula Roth, EVP of Pharmacy Services at Prochant
As Executive Vice President of Pharmacy Operations at Prochant, Paula leads an expert team focused on enhancing the home-based care industry through innovative technology and streamlined processes. With more than 20 years of experience in revenue cycle management for alternate sites of care, Paula leverages technology and teams to ensure clients achieve or exceed their financial targets.
Jon Love, President & Chief Growth Officer at MedEdge Solutions
Jon Love joins MedEdge with leadership experience in the infusion and specialty pharmacy industries. He has previously served in sales at WellSky, chief operating officer at Rock-Pond Solutions, and senior VP of pharmacy services at Prochant.
Pamela McIntyre, Founder and Owner of Expert Infusion Nurse Consulting
With 40 years of experience in infusion nursing, Pam founded Expert Infusion Nurse Consulting to advance excellence in infusion and mentor other infusion professionals. Her certifications include CRNI, IgCN, OCN, and VA-BC, and she has an immersive background in home infusion and ambulatory infusion in the fields of acute and chronic care, including oncology nursing.
Brandon Carpenter, President of MedEdge Solutions
Brandon Carpenter is the owner and founder of MedEdge Solutions. With more than 12 years of experience in pharmacy solutions, process improvement, and data analytics, Brandon takes an active role in each of their projects. Prior to forming MedEdge, Brandon was the Director of Products and Professional Services at Rock-Pond Solutions where he worked with over 250 pharmacies nationwide to solve problems ranging from system integrations, financial reporting, 340B, Limited Drug Distribution, and software management. He is a graduate of the University of Central Arkansas where he received his bachelor’s in business & information systems, as well as his Master of Business Administration.
Brian O’Sullivan, President of The O’Sullivan Group
Brian O’Sullivan formed The O’Sullivan Group, Inc. in February 1999 to serve health care providers with managed care and provider business development services. Over the years, The O’Sullivan Group has also been sought out by Medicare Advantage and Managed Medicaid plans to assist with network development needs. His vision was to bring real world know-how by offering the same level of service and expertise for both large and small companies that are enjoyed by major Fortune 1000 organizations.
